EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL)

Katarzyna Romejko iD, Magdalena Markowska iD, Stanisław Niemczyk

International Journal of Molecular Sciences · 21.06.2023 · 24 (13) · 10470

DOI: 10.3390/ijms241310470 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.06.2023. Verfasst von Katarzyna Romejko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine-National Research Institute, 128 Szaserów Street, 04-141 War…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Renal Insufficiency, Chronic, Acute Kidney Injury. Die Arbeit wurde bisher 259-mal zitiert (Crossref) und nennt 233 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neutrophil gelatinase-associated lipocalin (NGAL) is a 25-kDa protein that is secreted mostly by immune cells such as neutrophils, macrophages, and dendritic cells. Its production is stimulated in response to inflammation. The concentrations of NGAL can be measured in plasma, urine, and biological fluids such as peritoneal effluent. NGAL is known mainly as a biomarker of acute kidney injury and is released after tubular damage and during renal regeneration processes. NGAL is also elevated in chronic kidney disease and dialysis patients. It may play a role as a predictor of the progression of renal function decreases with complications and mortality due to kidney failure. NGAL is also useful in the diagnostic processes of cardiovascular diseases. It is highly expressed in injured heart tissue and atherosclerostic plaque; its serum concentrations correlate with the severity of heart failure and coronary artery disease. NGAL increases inflammatory states and its levels rise in arterial hypertension, obesity, diabetes, and metabolic complications such as insulin resistance, and is also involved in carcinogenesis. In this review, we present the current knowledge on NGAL and its involvement in different pathologies, especially its role in renal and cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesRenal Insufficiency, ChronicAcute Kidney InjuryHumansLipocalin-2Renal DialysisKidneyBiomarkers

Stichwörter der Autor:innen

NGALacute kidney injurycardiovascular complicationschronic kidney disease

Substanzen

Lipocalin-2Biomarkers

Autor:innen und Institutionen

  • Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine-National Research Institute, 128 Szaserów Street, 04-141 Warsaw, Poland.

ORCID-Profile: Katarzyna Romejko, Magdalena Markowska

Zitieren

APA

Romejko, K., Markowska, M., & Niemczyk, S. (2023). The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL). International Journal of Molecular Sciences, 24(13), 10470. https://doi.org/10.3390/ijms241310470

Vancouver

Romejko K, Markowska M, Niemczyk S. The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL). International Journal of Molecular Sciences. 2023;24(13):10470. doi:10.3390/ijms241310470

BibTeX
@article{Romejko2023,
  author = {Romejko, Katarzyna and Markowska, Magdalena and Niemczyk, Stanisław},
  title = {The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL)},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {13},
  pages = {10470},
  doi = {10.3390/ijms241310470}
}
Kostenlos starten →